Onychomycosis

This Week in Biotech: Anacor's FDA A-OK and AbbVie's Insatiable Urge to Buy Something
Motley Fool
Mon, 07/14/14 - 09:33 am
FDA
Anacor
Shire
M&A
AbbVie
Kerydin
Onychomycosis
The Race To The Market: Anacor and Valeant
Motley Fool
Wed, 06/18/14 - 11:26 am
Valeant Pharmaceuticals
Anacor
Onychomycosis
Jublia
Kerydin
Anacor Falls On Positive But Disappointing Toenail Fungus Data
TheStreet.com
Tue, 01/29/13 - 11:07 am
Anacor
Tavaborole
Onychomycosis
Anacor Readies Results From Pivotal Study of Toenail Fungus Drug
TheStreet.com
Tue, 01/15/13 - 11:40 am
Anacor
Onychomycosis
Tavaborole
Apricus will seek Canadian MycoVa approval in 2013
Yahoo/AP
Mon, 10/1/12 - 11:30 am
Apricus
Canada
MycoVa
Onychomycosis
Anacor Pharmaceuticals to Present Clinical Data on Tavaborole and AN2728 at Upcoming Medical Meetings
PharmiWeb
Sat, 05/5/12 - 04:54 pm
Tavaborole
Anacor
AN2728
atopic dermatitis
Onychomycosis
antifungals
Nitric BioTherapeutics Initiates Phase II Onychomycosis Study
Thu, 07/15/10 - 11:58 am
Nitric BioTherapeutics
Onychomycosis
Celtic Pharma Announces Initiation Of Phase III Trial Of TDT 067 For The Treatment Of Onychomycosis
Medical News Today
Sat, 05/1/10 - 11:13 am
Celtic Pharmaceutical Holdings
Onychomycosis
Nomir Medical's Noveon(R) Device Achieves 76 Percent Response Rate In Pivotal Trial For The Treatment Of Onychomycosis
Medical News Today
Sun, 03/8/09 - 12:47 pm
Onychomycosis
Nomir Medical